What Is Trace Chemotherapy Waste?

If your facility administers chemotherapy treatments, you already understand the gravity of handling hazardous drugs. But there’s one category of medical waste that trips up even well-run healthcare organizations: trace chemotherapy waste. Misclassifying or mishandling this waste can trigger serious regulatory violations, harm staff and patients, and expose your organization to steep fines. RedBags is here to break down exactly what trace chemo waste is, why it matters, and how to manage it correctly.

Defining Trace Chemotherapy Waste

Trace chemotherapy waste refers to materials that have come into contact with antineoplastic (cancer-fighting) drugs but contain only a residual amount of those agents — generally defined as less than 3% of the original volume remaining in or on the item. Common examples include empty IV bags and tubing used to deliver chemo drugs, gloves and gowns worn during drug preparation or administration, wipes and gauze used to clean up minor spills, and empty vials and syringes with minimal residual drug. This category is distinct from bulk chemotherapy waste, which contains more than 3% of the original drug volume and demands even more stringent handling.

Did You Know?

The National Institute for Occupational Safety and Health (NIOSH) publishes an annual list of hazardous drugs in healthcare settings. In 2024, more than 100 drugs appeared on this list — many of them standard chemotherapy agents. Even trace exposure to these drugs can cause serious health effects in healthcare workers over time.

How Federal Regulations Classify Trace Chemo Waste

The U.S. Environmental Protection Agency (EPA) regulates chemotherapy waste under the Resource Conservation and Recovery Act (RCRA). Some chemotherapy agents — such as chlorambucil, cyclophosphamide, and melphalan — appear on the EPA’s P-list (acutely hazardous wastes) or U-list (toxic hazardous wastes). When these specific drugs are involved, even trace-contaminated materials must be managed as RCRA hazardous waste, regardless of the residual amount. For other chemo agents not listed under RCRA, trace waste may be regulated as state-regulated medical waste, but facilities are still responsible for meeting applicable state rules. The 2019 EPA Pharmaceutical Waste Rule added further requirements, prohibiting disposal of hazardous pharmaceutical waste — including many chemo agents — down the drain or in municipal solid waste.

How to Properly Contain Trace Chemo Waste

Proper segregation at the point of care is the cornerstone of compliant trace chemo waste management. The industry standard is to use yellow containers — yellow bags, sharps containers, or lidded bins — specifically marked for trace chemotherapy waste. This color-coding helps staff instantly distinguish chemo waste from red-bag infectious waste or general solid waste. Key containment rules include: never placing trace chemo waste in a red biohazard bag, keeping containers sealed and upright to prevent leaks, using puncture-resistant yellow sharps containers for needles and syringes used in chemo administration, and labeling all containers with the words “Chemotherapy Waste” and applicable hazardous waste codes if RCRA-regulated.

Ready to Stay Compliant?

Save up to 25% with our Med/Shred Combo. Serving businesses across the Northeast, Mid-Atlantic, and beyond.

Get a Free Quote →

The Risks of Non-Compliance

Failing to properly manage trace chemotherapy waste carries significant consequences. From a regulatory standpoint, facilities can face EPA fines ranging from thousands to hundreds of thousands of dollars per violation per day. State environmental agencies may levy additional penalties. Beyond fines, improper disposal can contaminate water supplies and harm the broader environment — a serious public health concern given that many chemo agents are known carcinogens, mutagens, or teratogens. For healthcare workers, chronic low-level exposure to chemo waste residues has been linked to increased risk of certain cancers, reproductive problems, and organ damage. Facilities that fail to train staff on proper trace chemo waste segregation put both employees and patients at risk.

Did You Know?

According to the EPA, the healthcare sector generates approximately 6,000 tons of hazardous pharmaceutical waste annually in the United States, a significant portion of which includes chemotherapy-related waste. Proper disposal protects waterways, wildlife, and communities from these potent compounds.

Who Generates Trace Chemo Waste?

It’s not only oncology centers and cancer hospitals that must worry about trace chemo waste. Many types of facilities administer chemotherapy drugs or handle them in some capacity, including physician offices with in-office infusion suites, outpatient infusion centers and cancer clinics, home health agencies that supply and manage chemo administration in patient homes, veterinary clinics that use antineoplastic drugs in animal care, and long-term care facilities with patients on oral chemo regimens. No matter the size or type of your organization, if you handle chemotherapy agents, you are responsible for the proper classification and disposal of all resulting waste — including trace amounts.

Best Practices for Trace Chemo Waste Management

  • Segregate at the point of generation: Train all staff to place trace chemo items directly into yellow chemo waste containers immediately after use — never in the trash or red bags.
  • Know your RCRA-listed drugs: Maintain an up-to-date list of P-listed and U-listed chemotherapy agents used at your facility and ensure they are routed to licensed hazardous waste disposal.
  • Document everything: Maintain waste manifests, training records, and disposal receipts. RCRA requires a paper trail from waste generation through final disposal.
  • Partner with a licensed medical waste disposal company: Work with a company — like RedBags — that is licensed to handle and transport chemotherapy waste in full compliance with federal and state regulations.
  • Conduct regular staff training: OSHA and accreditation bodies such as The Joint Commission expect annual (at minimum) training on hazardous drug handling and waste disposal procedures.
  • Review state-specific rules: Many states — including New York, New Jersey, Pennsylvania, and Maryland — have regulations that go beyond federal minimums for chemo waste. Your disposal partner should be well-versed in applicable state rules.

How RedBags Handles Trace Chemotherapy Waste

RedBags provides compliant, convenient chemotherapy waste pickup and disposal for healthcare facilities throughout the Northeast and Mid-Atlantic. Our team understands the nuances of RCRA P-list and U-list waste, state pharmaceutical waste regulations, and the practical challenges of chemotherapy waste segregation in busy clinical settings. We supply properly labeled yellow chemo waste containers, schedule reliable pickups, provide complete documentation for your records, and ensure all waste is treated and disposed of at licensed facilities. We also offer staff training resources to help your team stay sharp on proper waste segregation protocols. Whether you’re a solo oncology practice or a large hospital system, RedBags has the scale and expertise to keep you compliant.

Trust RedBags for Your Medical Waste Disposal

Our experts are ready to help you stay compliant, reduce risk, and save money. Call us at 1-844-RED-BAGS (1-844-733-2247) or request a free quote online.

Contact Us Today Call 1-844-RED-BAGS